U3 Pharma
U3 Pharma specializes in the development of targeted cancer drugs within the pharmaceutical industry.
Launch date
Employees
Market cap
-
Enterprise valuation
€124—185m (Dealroom.co estimates May 2006.)
Company register number HRB 177122
Planegg Bavaria (HQ & founding location)
Date | Investors | Amount | Round |
---|---|---|---|
N/A | Spinout | ||
€14.4m | Early VC | ||
* | $34.0m | Late VC | |
N/A | Acquisition | ||
Total Funding | €45.3m |
Related Content
Recent News about U3 Pharma
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.